BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18519512)

  • 1. Acute leukemia in children with Down's syndrome: the importance of population based study.
    James R; Lightfoot T; Simpson J; Moorman AV; Roman E; Kinsey S;
    Haematologica; 2008 Aug; 93(8):1262-3. PubMed ID: 18519512
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis of Down's syndrome with acute leukaemia.
    Levitt GA; Stiller CA; Chessells JM
    Arch Dis Child; 1990 Feb; 65(2):212-6. PubMed ID: 2138446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Child and maternal household chemical exposure and the risk of acute leukemia in children with Down's syndrome: a report from the Children's Oncology Group.
    Alderton LE; Spector LG; Blair CK; Roesler M; Olshan AF; Robison LL; Ross JA
    Am J Epidemiol; 2006 Aug; 164(3):212-21. PubMed ID: 16760223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute leukemia in Down's syndrome.
    Athale UH; Nair R; Kadam P; Pai SK; Advani SH
    Indian Pediatr; 1990 Jan; 27(1):73-5. PubMed ID: 2141827
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transient abnormal myelopoiesis followed by acute leukemia in children with Down syndrome].
    Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
    Rinsho Ketsueki; 1990 Dec; 31(12):1939-44. PubMed ID: 2150419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down's syndrome and acute leukaemia.
    Lancet; 1973 Jan; 1(7793):53. PubMed ID: 4118582
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
    Forestier E; Izraeli S; Beverloo B; Haas O; Pession A; Michalová K; Stark B; Harrison CJ; Teigler-Schlegel A; Johansson B
    Blood; 2008 Feb; 111(3):1575-83. PubMed ID: 17971484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome.
    Pawlowska AB; Davies SM; Orchard PJ; Wagner JE; Ramsay NK
    Bone Marrow Transplant; 1996 Aug; 18(2):453-5. PubMed ID: 8864463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
    Roncadin C; Hitzler J; Downie A; Montour-Proulx I; Alyman C; Cairney E; Spiegler BJ
    Pediatr Blood Cancer; 2015 May; 62(5):854-8. PubMed ID: 25545182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
    Bercovich D; Ganmore I; Scott LM; Wainreb G; Birger Y; Elimelech A; Shochat C; Cazzaniga G; Biondi A; Basso G; Cario G; Schrappe M; Stanulla M; Strehl S; Haas OA; Mann G; Binder V; Borkhardt A; Kempski H; Trka J; Bielorei B; Avigad S; Stark B; Smith O; Dastugue N; Bourquin JP; Tal NB; Green AR; Izraeli S
    Lancet; 2008 Oct; 372(9648):1484-92. PubMed ID: 18805579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal health conditions during pregnancy and acute leukemia in children with Down syndrome: A Children's Oncology Group study.
    Ognjanovic S; Puumala S; Spector LG; Smith FO; Robison LL; Olshan AF; Ross JA
    Pediatr Blood Cancer; 2009 May; 52(5):602-8. PubMed ID: 19148952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome?
    Frost BM; Gustafsson G; Larsson R; Nygren P; Lönnerholm G
    Leukemia; 2000 May; 14(5):943-4. PubMed ID: 10803530
    [No Abstract]   [Full Text] [Related]  

  • 14. [Association of congenital chromosome abnormalities and malignant diseases].
    Erzsébet B; Andrea N; Róbert S; Eva O
    Orv Hetil; 1996 Feb; 137(5):227-31. PubMed ID: 8882440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of leukaemia and solid tumours in individuals with Down's syndrome.
    Hasle H; Clemmensen IH; Mikkelsen M
    Lancet; 2000 Jan; 355(9199):165-9. PubMed ID: 10675114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down's syndrome and acute leukemia: myeloblastic or lymphoblastic? Report of forty-three cases and review of the literature.
    Rosner F; Lee SL
    Am J Med; 1972 Aug; 53(2):203-18. PubMed ID: 4262013
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.
    Blair CK; Roesler M; Xie Y; Gamis AS; Olshan AF; Heerema NA; Robison LL; Ross JA;
    Paediatr Perinat Epidemiol; 2008 May; 22(3):288-95. PubMed ID: 18426524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down's syndrome and acute leukaemia.
    Lancet; 1972 Dec; 2(7788):1187. PubMed ID: 4117604
    [No Abstract]   [Full Text] [Related]  

  • 19. Down's syndrome with acute myeloid leukemia.
    Singh VP; Sundar S; Kumar K; Shukla J; Dube B
    J Assoc Physicians India; 1994 Aug; 42(8):621. PubMed ID: 7868556
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome.
    Rubin CM; Mick R; Johnson FL
    Bone Marrow Transplant; 1996 Sep; 18(3):533-40. PubMed ID: 8879614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.